These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 31165274
1. In the Search of Glycoside-Based Molecules as Antidiabetic Agents. Pałasz A, Cież D, Trzewik B, Miszczak K, Tynor G, Bazan B. Top Curr Chem (Cham); 2019 Jun 05; 377(4):19. PubMed ID: 31165274 [Abstract] [Full Text] [Related]
2. Recent progress of sodium-glucose transporter 2 inhibitors as potential antidiabetic agents. Zhang Y, Ban H, Yu R, Wang Z, Zhang D. Future Med Chem; 2018 May 01; 10(10):1261-1276. PubMed ID: 29749749 [Abstract] [Full Text] [Related]
3. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments. Somsák L, Nagya V, Hadady Z, Docsa T, Gergely P. Curr Pharm Des; 2003 May 01; 9(15):1177-89. PubMed ID: 12769745 [Abstract] [Full Text] [Related]
4. Synthesis of triazole-linked beta-C-glycosyl dimers as inhibitors of PTP1B. Lin L, Shen Q, Chen GR, Xie J. Bioorg Med Chem; 2008 Nov 15; 16(22):9757-63. PubMed ID: 18922697 [Abstract] [Full Text] [Related]
5. Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors. Patel D, Jain M, Shah SR, Bahekar R, Jadav P, Darji B, Siriki Y, Bandyopadhyay D, Joharapurkar A, Kshirsagar S, Patel H, Shaikh M, Sairam KV, Patel P. ChemMedChem; 2011 Jun 06; 6(6):1011-6. PubMed ID: 21506278 [No Abstract] [Full Text] [Related]
6. Beta-C-glycosiduronic acids and beta-C-glycosyl compounds: new PTP1B inhibitors. Lin L, Shen Q, Chen GR, Xie J. Bioorg Med Chem Lett; 2008 Dec 15; 18(24):6348-51. PubMed ID: 18993066 [Abstract] [Full Text] [Related]
10. Inhibition of glycogen phosphorylase in the context of type 2 diabetes, with focus on recent inhibitors bound at the active site. Praly JP, Vidal S. Mini Rev Med Chem; 2010 Oct 15; 10(12):1102-26. PubMed ID: 20716051 [Abstract] [Full Text] [Related]
14. Protein tyrosine phosphatase 1B inhibitors as antidiabetic agents - A brief review. Verma M, Gupta SJ, Chaudhary A, Garg VK. Bioorg Chem; 2017 Feb 15; 70():267-283. PubMed ID: 28043717 [Abstract] [Full Text] [Related]
15. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition. Goyard D, Kónya B, Chajistamatiou AS, Chrysina ED, Leroy J, Balzarin S, Tournier M, Tousch D, Petit P, Duret C, Maurel P, Somsák L, Docsa T, Gergely P, Praly JP, Azay-Milhau J, Vidal S. Eur J Med Chem; 2016 Jan 27; 108():444-454. PubMed ID: 26708111 [Abstract] [Full Text] [Related]
16. Glycogen phosphorylase inhibitors: a patent review (2013 - 2015). Donnier-Maréchal M, Vidal S. Expert Opin Ther Pat; 2016 Jan 27; 26(2):199-212. PubMed ID: 26666989 [Abstract] [Full Text] [Related]
17. Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases. Zhang L, Chen J, Gong Y, Liu J, Zhang L, Hua W, Sun H. Chem Biodivers; 2009 Jun 27; 6(6):864-74. PubMed ID: 19551727 [Abstract] [Full Text] [Related]
18. Exploring the Dual Inhibitory Activity of Novel Anthranilic Acid Derivatives towards α-Glucosidase and Glycogen Phosphorylase Antidiabetic Targets: Design, In Vitro Enzyme Assay, and Docking Studies. Ihmaid S. Molecules; 2018 May 29; 23(6):. PubMed ID: 29844263 [Abstract] [Full Text] [Related]
20. In Search for Multi-Target Ligands as Potential Agents for Diabetes Mellitus and Its Complications-A Structure-Activity Relationship Study on Inhibitors of Aldose Reductase and Protein Tyrosine Phosphatase 1B. Ottanà R, Paoli P, Cappiello M, Nguyen TN, Adornato I, Del Corso A, Genovese M, Nesi I, Moschini R, Naß A, Wolber G, Maccari R. Molecules; 2021 Jan 10; 26(2):. PubMed ID: 33435264 [Abstract] [Full Text] [Related] Page: [Next] [New Search]